Trademark: 97832368
Status Date
Tuesday, January 30, 2024
Filing Date
Friday, March 10, 2023
Published for Opposition
Tuesday, January 30, 2024
5 Pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of bradykinin mediated inflammatory disorders; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders; pharmaceutical preparations containing sebetralstat for the treatment of angioedema, hereditary angioedema, bradykinin mediated inflammatory disorders, plasma kallikrein or factor XIIa mediated diseases or disorders, or diseases and disorders mediated by the contact activation system
Jan 30, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 30, 2024
Published For Opposition
Jan 10, 2024
Notification Of Notice Of Publication E-Mailed
Dec 27, 2023
Approved For Pub - Principal Register
Dec 26, 2023
Teas/Email Correspondence Entered
Dec 26, 2023
Correspondence Received In Law Office
Dec 26, 2023
Assigned To Lie
Jul 31, 2023
Teas Response To Office Action Received
May 12, 2023
Notification Of Non-Final Action E-Mailed
May 12, 2023
Non-Final Action E-Mailed
May 12, 2023
Non-Final Action Written
May 5, 2023
Assigned To Examiner
Mar 30, 2023
New Application Office Supplied Data Entered
Mar 14, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24